Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)

Sweden · Delayed Price · Currency is SEK

0.2400

-0.0020 (-0.83%)

At close: Jun 25, 2026

-47.37% (1Y)

Market Cap	11.52M -68.6%
Revenue (ttm)	6.38M -19.6%
Net Income	-9.31M
EPS	-0.27
Shares Out	51.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,048
Open	0.2420
Previous Close	0.2420
Day's Range	0.1985 - 0.2420
52-Week Range	0.1720 - 0.5850
Beta	-0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About XSAT:ISAB

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2004

Employees 5

Stock Exchange Spotlight Stock Market

Ticker Symbol ISAB

Full Company Profile

Financial Performance

In 2025, XSAT:ISAB's revenue was 3.04 million, a decrease of -72.47% compared to the previous year's 11.05 million. Losses were -10.16 million, 97.4% more than in 2024.

Financial Statements